Exploring the Anticancer Properties of Quinoxaline-Based Molecules: A Systematic Review

Eman K A Abdelall1, Heba A H Elshemy1, Noha Ryad2

  • 1Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Beni-Suef University, Beni-Suef, Egypt.

PubMed

Insights

Quinoxaline derivatives show promise as novel anticancer agents, offering potential treatments with fewer side effects than traditional chemotherapy. This review highlights their efficacy in combating cancer pathways.

Area of Science:

  • Medicinal Chemistry
  • Pharmacology
  • Oncology

Background:

  • Cancer remains a leading global cause of death, necessitating new therapeutic strategies.
  • Current chemotherapy drugs often lack specificity and cause significant adverse effects.
  • Quinoxaline derivatives are emerging as a promising class of compounds for cancer treatment.

Purpose of the Study:

  • To review and synthesize research on the anticancer efficacy of quinoxaline derivatives.
  • To summarize findings from studies published between 2015 and 2024.
  • To highlight the potential of quinoxaline derivatives in future cancer therapies.

Main Methods:

  • Comprehensive literature search of scientific databases.
  • Inclusion of studies focusing on quinoxaline derivatives' anticancer activity.
  • Analysis and summarization of reported efficacy and mechanisms of action.

Main Results:

  • Numerous quinoxaline derivatives demonstrate significant anticancer activity against various cancer types.
  • These compounds show potential in inhibiting key cancer-related pathways and enzymes.
  • The review covers a decade of research (2015-2024) showcasing consistent findings.

Conclusions:

  • Quinoxaline derivatives represent a promising scaffold for developing novel anticancer drugs.
  • Their targeted action may offer improved specificity and reduced side effects compared to conventional chemotherapy.
  • Further research and clinical trials are warranted to fully realize their therapeutic potential.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
6.3K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
4.9K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
2.0K